Rajiv Malik
Mr. Rajiv Malik is a President & Director at Viatris, Inc., a Chief Executive Officer, Director & MD at Eurofins Advinus Ltd., a President at Mylan (Pty) Ltd. and a President & Director at Mylan Pharmaceuticals, Inc. He is on the Board of Directors at Viatris, Inc., Eurofins Advinus Ltd., Graposs Edutech Pvt Ltd. and Mylan Pharmaceuticals, Inc. Mr. Malik was previously employed as a Head-Global Operations by Mylan Laboratories, Inc., a President & Executive Director by Mylan NV, a President & Director by Mylan, Inc., a Chief Executive Officer by Matrix Laboratories Ltd., a Head-Global Development & Registrations by Sandoz GmbH, a Head-Global Regulatory Affairs & Pharma Research by Ranbaxy Laboratories Ltd., and a Secretary by ANG Industries Ltd. He received his graduate degree from Panjab University Chandigarh.
Transactions
| 03/02/2022 | 1,606 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/02/2022 | 29,210 | Derivative/Non-derivative trans. at $10.48 per share. | 306,121 |
| 03/02/2022 | 67,180 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/02/2022 | 22,884 | Derivative/Non-derivative trans. at $10.48 per share. | 239,825 |
| 03/02/2022 | 52,631 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/02/2022 | 54,648 | Derivative/Non-derivative trans. at $10.48 per share. | 572,712 |
| 03/02/2022 | 125,684 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/02/2022 | 14,562 | Derivative/Non-derivative trans. at $10.48 per share. | 152,610 |
| 03/02/2022 | 699 | Derivative/Non-derivative trans. at $10.48 per share. | 7,326 |
| 03/02/2022 | 33,516 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/02/2021 | 52,632 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/02/2021 | 33,515 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/02/2021 | 73,225 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/02/2021 | 14,645 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 11/16/2020 | 88,365 | Award at $0 per share. | 0 |
| 11/16/2020 | 88,365 | 0 | |
| 11/16/2020 | 459,699 | Award at $0 per share. | 0 |
| 11/16/2020 | 459,699 | 0 | |
| 03/03/2020 | 13,677 | Derivative/Non-derivative trans. at $16.29 per share. | 222,799 |
| 03/03/2020 | 30,988 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/03/2020 | 5,471 | Derivative/Non-derivative trans. at $16.29 per share. | 89,123 |
| 03/03/2020 | 12,395 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/02/2020 | 14,793 | Derivative/Non-derivative trans. at $17.48 per share. | 258,582 |
| 03/02/2020 | 33,516 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/02/2020 | 6,464 | Derivative/Non-derivative trans. at $17.48 per share. | 112,991 |
| 03/02/2020 | 14,645 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/03/2019 | 5,471 | Derivative/Non-derivative trans. at $27.45 per share. | 150,179 |
| 03/03/2019 | 12,395 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/02/2019 | 6,464 | Derivative/Non-derivative trans. at $27.45 per share. | 177,437 |
| 03/02/2019 | 14,645 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/01/2019 | 324,061 | 0 | |
| 02/19/2019 | 6,067 | Derivative/Non-derivative trans. at $32.1 per share. | 194,751 |
| 02/19/2019 | 14,589 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 02/17/2019 | 8,834 | Derivative/Non-derivative trans. at $31.84 per share. | 281,275 |
| 02/17/2019 | 22,024 | Derivative/Non-derivative trans. at $0 per share. | 0 |
